James Hambro & Partners Pfizer Inc Transaction History

James Hambro & Partners

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 28, 2021	SELL	$33.49 - $37.77 $76,591 - $86,379	-2,287 Reduced 7.38%	28,700 $1.04 Million
Q4 2020 Jan 14, 2021	BUY	$33.47 - $42.56 $76,545 - $97,334	2,287 Added 7.97%	30,987 $1.14 Million
Q2 2020 Jul 13, 2020	SELL	$30.12 - $36.54 $104,215 - $126,428	-3,460 Reduced 10.76%	28,700 $938,000
Q4 2019 Feb 04, 2020	SELL	$32.92 - $37.36 $3.02 Million - $3.42 Million	-91,635 Reduced 74.02%	32,160 $1.26 Million
Q3 2019 Nov 04, 2019	SELL	$32.49 - $42.13 $4.01 Million - $5.19 Million	-123,293 Reduced 49.9%	123,795 $4.45 Million
Q1 2019 Apr 25, 2019	BUY	$37.5 - $41.2 $8.76 Million - $9.63 Million	233,728 Added 1749.46%	247,088 $10.5 Million
Q3 2018 Oct 18, 2018	SELL	$34.47 - $41.81 $38,606 - $46,827	-1,120 Reduced 7.73%	13,360 $589,000
Q2 2018 Jul 12, 2018	SELL	$32.98 - $35.16 $149,729 - $159,626	-4,540 Reduced 23.87%	14,480 $526,000
Q4 2017 Oct 18, 2018	BUY	$33.26 - $35.29 $146,344 - $155,276	4,400 Added 30.1%	19,020 $690,000
Q4 2017 Feb 13, 2018	BUY	$33.26 - $35.29 $486,261 - $515,939	14,620	14,620 $530,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of James Hambro & Partners, based on Form 13F filings with the SEC.

Stay updated on James Hambro & Partners with notifications on news.